AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets
Authors: Fuller, GN Hess, KR Rhee, CH Yung, WKA Sawaya, RA Bruner, JM Zhang, W
Citation: Gn. Fuller et al., Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets, BRAIN PATH, 12(1), 2002, pp. 108-116
gamma-radiation sensitivity and risk of glioma
Authors: Bondy, ML Wang, LE El-Zein, R de Andrade, M Selvan, MS Bruner, JM Levin, VA Yung, WKA Adatto, P Wei, QY
Citation: Ml. Bondy et al., gamma-radiation sensitivity and risk of glioma, J NAT CANC, 93(20), 2001, pp. 1553-1557
Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998
Authors: Kunschner, LJ Kuttesch, J Hess, K Yung, WKA
Citation: Lj. Kunschner et al., Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998, NEURO-ONCOL, 3(3), 2001, pp. 167-173
Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis
Authors: Cerrato, JA Yung, WKA Liu, TJ
Citation: Ja. Cerrato et al., Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis, NEURO-ONCOL, 3(2), 2001, pp. 113-122
Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells
Authors: Mohanam, S Jasti, SL Kondraganti, SR Chandrasekar, N Kin, Y Fuller, GN Lakka, SS Kyritsis, AP Dinh, DH Olivero, WC Gujrati, M Yung, WKA Rao, JS
Citation: S. Mohanam et al., Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells, CLIN CANC R, 7(8), 2001, pp. 2519-2526
Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines
Authors: Lakka, SS Rajagopal, R Rajan, MK Mohan, PM Adachi, Y Dink, DH Olivero, WC Gujrati, M Ali-Osman, F Roth, JA Yung, WKA Kyritsis, AP Rao, JS
Citation: Ss. Lakka et al., Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines, CLIN CANC R, 7(4), 2001, pp. 1087-1093
Co-expression of E2F-2 enhances the p53 anti-cancer effect in human gliomacells
Authors: Mitlianga, PG Kyritsis, AP Gomez-Manzano, C Lemoine, MG Hu, M Liu, TJ Yung, WKA Fueyo, J
Citation: Pg. Mitlianga et al., Co-expression of E2F-2 enhances the p53 anti-cancer effect in human gliomacells, INT J ONCOL, 18(2), 2001, pp. 343-347
Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN
Authors: Koul, D Parthasarathy, R Shen, RJ Davies, MA Jasser, SA Chintala, SK Rao, JS Sun, Y Benvenisite, EN Liu, TJ Yung, WKA
Citation: D. Koul et al., Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN, ONCOGENE, 20(46), 2001, pp. 6669-6678
Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer
Authors: Wang, MLH Yung, WKA Royce, ME Schomer, DF Theriault, RL
Citation: Mlh. Wang et al., Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer, AM J CL ONC, 24(4), 2001, pp. 421-424
Delivery of cell cycle genes to block astrocytoma growth
Authors: Fueyo, J Gomez-Manzano, C Liu, TJ Yung, WKA
Citation: J. Fueyo et al., Delivery of cell cycle genes to block astrocytoma growth, J NEURO-ONC, 51(3), 2001, pp. 277-287
Future directions for temozolomide therapy
Authors: Yung, WKA
Citation: Wka. Yung, Future directions for temozolomide therapy, SEMIN ONCOL, 28(4), 2001, pp. 43-46
Tumor suppressor MMAC/PTEN inhibits cytokine-induced NF kappa B activationwithout interfering with the I kappa B degradation pathway
Authors: Koul, D Yao, YX Abbruzzese, JL Yung, WKA Reddy, SAG
Citation: D. Koul et al., Tumor suppressor MMAC/PTEN inhibits cytokine-induced NF kappa B activationwithout interfering with the I kappa B degradation pathway, J BIOL CHEM, 276(14), 2001, pp. 11402-11408
Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2
Authors: Gomez-Manzano, C Mitlianga, P Fueyo, J Lee, HY Hu, M Spurgers, KB Glass, TL Koul, D Liu, TJ McDonnell, TJ Yung, WKA
Citation: C. Gomez-manzano et al., Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2, CANCER RES, 61(18), 2001, pp. 6693-6697
Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
Authors: Im, SA Kim, JS Gomez-Manzano, C Fueyo, J Liu, TJ Cho, MS Seong, CM Lee, SN Hong, YK Yung, WKA
Citation: Sa. Im et al., Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF, BR J CANC, 84(9), 2001, pp. 1252-1257
Effect of disease burden on health-related quality of life in patients with malignant gliomas
Authors: Osoba, D Brada, M Prados, MD Yung, WKA
Citation: D. Osoba et al., Effect of disease burden on health-related quality of life in patients with malignant gliomas, NEURO-ONCOL, 2(4), 2000, pp. 221-228
Inhibition of cell growth in human glioblastoma cell lines by farnesyltransferase inhibitor SCH66336
Authors: Glass, TL Liu, TJ Yung, WKA
Citation: Tl. Glass et al., Inhibition of cell growth in human glioblastoma cell lines by farnesyltransferase inhibitor SCH66336, NEURO-ONCOL, 2(3), 2000, pp. 151-158
Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development
Authors: Hong, YK Chung, DS Joe, AA Yang, YJ Kim, KM Park, YS Yung, WKA Kang, JK
Citation: Yk. Hong et al., Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development, CLIN CANC R, 6(8), 2000, pp. 3354-3360
The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines
Authors: Ke, LD Shi, YX Im, SA Chen, XS Yung, WKA
Citation: Ld. Ke et al., The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines, CLIN CANC R, 6(6), 2000, pp. 2562-2572
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazin N-(2-chloroethyl)-N '-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
Authors: Levin, VA Uhm, JH Jaeckle, KA Choucair, A Flynn, PJ Yung, WKA Prados, MD Bruner, JM Chang, SM Kyritsis, AP Gleason, MJ Hess, KR
Citation: Va. Levin et al., Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazin N-(2-chloroethyl)-N '-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme, CLIN CANC R, 6(10), 2000, pp. 3878-3884
Potentials and limitations of adenovirus-p53 gene therapy for brain tumors
Authors: Hong, YK Joe, YA Yang, YJ Lee, KS Son, BC Juen, SS Chung, DS Cho, KK Park, CK Kim, MC Kim, HK Yung, WKA Kang, JK
Citation: Yk. Hong et al., Potentials and limitations of adenovirus-p53 gene therapy for brain tumors, J KOR MED S, 15(3), 2000, pp. 315-322
Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide
Authors: Osoba, D Brada, M Yung, WKA Prados, MD
Citation: D. Osoba et al., Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide, EUR J CANC, 36(14), 2000, pp. 1788-1795
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo (vol 19, pg 2, 2000)
Authors: Fueyo, J Gomez-Manzano, C Alemany, R Lee, PSN McDonnell, TJ Mitlianga, P Shi, YX Levin, VA Yung, WKA Kyritsis, AP
Citation: J. Fueyo et al., A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo (vol 19, pg 2, 2000), ONCOGENE, 19(43), 2000, pp. 5038-5038
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Authors: Fueyo, J Gomez-Manzano, C Alemany, R Lee, PSY McDonnell, TJ Mitlianga, P Shi, YX Levin, VA Yung, WKA Kyritsis, AP
Citation: J. Fueyo et al., A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo, ONCOGENE, 19(1), 2000, pp. 2-12
A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards
Authors: Ke, LD Chen, Z Yung, WKA
Citation: Ld. Ke et al., A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards, MOL CELL PR, 14(2), 2000, pp. 127-135
Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme
Authors: Osoba, D Brada, M Yung, WKA Prados, M
Citation: D. Osoba et al., Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme, J CL ONCOL, 18(7), 2000, pp. 1481-1491
Risultati: 1-25 | 26-49